Vitamin tablets vs gummies: Which format is best for your brand? Are you confused about this?
There is no “better” dosage form, only a “more suitable” dosage form. Dosage form selection is essentially a matter of formulation constraints. For low-dose, highly concentrated active ingredients, gummies are naturally suitable due to their small size and sufficient volume. However, for minerals like calcium and magnesium that require large doses to be effective, or for compound formulations containing seven or eight ingredients, gummies are too large to fit. Capsules, tablets, and powders are physically feasible choices.
Absorption rate and bioavailability
The most common question retail buyers ask private label manufacturers is: “Are vitamin gummies really as effective as regular dosage forms such as tablets or capsules?”
In the past, some established manufacturers strongly promoted the idea that vitamin gummies were merely overpriced candies with no real health benefits. However, recent clinical research has revealed a completely different story.
Factual verification regarding the equivalence of efficacy
A landmark 12-week clinical pilot study conducted by Luminary Vitamins and evaluated by neuroscientists showed that personalized vitamin D3 gummies were as effective as traditional softgels in increasing and maintaining serum vitamin D3 levels.
A cross-bioequivalence study published in the journal Nutrients shows that vitamin D3 gummies may achieve better gastrointestinal absorption than standard tablets in certain populations.
Why does dosage form determine bioavailability?
Tablets: This type of dosage form requires a significant amount of mechanical breakdown in the stomach. If manufacturers bind the tablet excipients (fillers) too tightly, the tablet may not dissolve completely during digestion.
Gummies: The act of chewing activates salivary enzymes to break them down. By the time the gummies enter the stomach, they have already released nutrients into a form that the body can absorb easily.
More realistic metrics than absorption rate: adherence and repeat purchases
In the Luminary study, there’s a statistic that’s more noteworthy for B2B clients than the absorption rate conclusion: 79% of the gummy group consistently ate them daily, and 63% explicitly stated they preferred gummies to tablets. One participant even commented, “Tablets taste terrible, but I’m really looking forward to the gummies.”
These are the metrics that brands should really be focusing on. A 2024 consumer survey by the CRN (Council for Responsible Nutrition) showed that 75% of American adults take dietary supplements, and 71% of users are brand loyal, but many non-users cited “disliking pills” as a reason for not taking them. Subscription-based DTC brands cannot easily rely on users to perceive absorption differences; instead, users judge products by taste and their ability to take them consistently, and these factors directly determine monthly retention rates and lifetime value—which is why gummies have outperformed traditional capsules in the subscription e-commerce market in recent years.
What is the cost difference between gummies and tablets?
This is something brand blogs won’t tell you, but it’s crucial for product selection decisions. Supply chain data shows that the minimum order quantity for capsules is generally 1,000-2,000 units, while tablets are even lower, with some contract manufacturers allowing small-batch orders of 250-1,000 units. Gummies, due to the need for boiling, shaping, and drying, generally have a minimum order quantity of 5,000-20,000 bottles, and their unit production cost is about 10%-20% higher than capsules (mainly due to the cost of the sugar, gelatin/pectin, and flavor formulation). For new brands testing their first product, gummies face greater cash flow pressure and inventory risk.
The market ceiling for this category is indeed rising: projections show that the gummy vitamins segment will reach approximately $9.3 billion in 2026 and grow to around $12.7 billion by 2030, with a compound annual growth rate of about 8%. If we include gummy functional supplements containing probiotics and Omega-3, the market size already exceeded $27 billion in 2025. Adults and older consumers now drive most of the growth in the vitamin gummy market, transforming it from a children’s category into a mainstream supplement segment.
How to choose for different groups of people and product categories?
Targeting children, the elderly, and people with swallowing difficulties: Gummies/chewable tablets have a clear advantage, which is why these two customer groups have always accounted for the largest share of the gummy market.
High doses of minerals (such as calcium and magnesium) or multi-component formulations require amounts that capsules, tablets, and gummies cannot effectively accommodate.
When products primarily target fat-soluble vitamins (D, E, K, and fish oil), manufacturers can consider liquid emulsification or soft capsules, but they must factor in the costs of antioxidant protection and cold chain requirements into pricing.
Probiotics are the main selling point: whether it’s gummies or capsules, the core barrier lies in whether the encapsulation technology can allow live bacteria to reach the intestines alive; the dosage form itself is not the deciding factor.
Go through professional channels: CRN data shows that users who purchase supplements through doctors spend a median of $100 per month, significantly higher than other channels. This customer group is more attracted to the “clinical feel,” and the packaging language of tablets and capsules is usually more appealing than that of gummies.
What truly determines product quality are these unseen factors.
A simple yet easily overlooked criterion: aside from dosage form selection, what truly determines the reliability of a supplement is whether the manufacturing process is up to standard. Specifically, when selecting products and screening suppliers, you can check these points:
Whether the factory has cGMP certification is a basic requirement; suppliers without this certification can basically be eliminated.
Have you conducted third-party purity and heavy metal testing? Can you provide a certificate of authenticity (COA)?
Does the main ingredient have support from human clinical trials, or is it only at the stage of animal or in vitro experiments?
Are the dosages on the Supplement Facts accurate enough to withstand scrutiny? Are there any cases where the “concept dosage” is far lower than the clinically effective dosage?
These points are unrelated to the dosage form itself; capsules, tablets, and gummies can all lead to problems, and they can all be done very well. For independent websites, this part of due diligence is far more important than agonizing over “gummy or tablet.”
Several questions to ask yourself before selecting products
What dosage of your core ingredient is required? If it’s a high-dose mineral or compound, gummies can basically be ruled out.
Is the target customer group children, the elderly, people with swallowing difficulties, or those who focus on ingredient quality or use professional channels?
Are you willing to accept the high minimum order quantity and greater cash flow pressure associated with gummies?
Are there any special requirements regarding the source of titanium dioxide and gelatin, and the compliance classification of gummies in the target overseas markets?
Can the warehousing and logistics conditions withstand the heat and moisture sensitivity of gummies?
Frequently Asked Questions
There is no consistent evidence to support this. Controlled studies on vitamin D show that the serum enhancement effects of both are similar; what truly affects absorption is the specific delivery process (liposomes, emulsification technology), rather than the external form of gummies or tablets.
From the perspective of minimum order quantity and cash flow, capsules/tablets have a lower barrier to entry (starting at 1,000 units), while gummies usually require more than 5,000 units and have a higher unit cost, making them suitable for brands that have validated demand and have a budget to enter the market.
The niche market is still growing at an average annual rate of 8%-9%, and the proportion of adults and the elderly is rising. However, competition is much fiercer than it was five years ago. Differentiation should focus on specific functional ingredients and scenario positioning, rather than general selling points such as “gummy candies taste better than pills”.
Conclusion
Ultimately, there is no single “right answer” when it comes to dosage forms. Gummies, tablets, capsules, and liquids each have their own physical constraints and ideal use cases. What truly warrants your time and verification are supplier certifications, test reports, and raw material grades—not the specific dosage form itself. Once you clearly understand your target audience, ingredient dosages, compliance requirements, and supply chain capabilities, you can make product selection decisions more straightforwardly and allow the market to validate the rest.
